Kriya Therapeutics, Inc.
Last verified 2026-05-05. JSON
| Total raised | $400.0M |
|---|---|
| Latest round | Funding round, $320.8M, 2025-09-10 |
| Founded | 2019 |
| Headquarters | MORRISVILLE, NC |
| Industry | bio |
| Stage | unknown |
| Website | kriyatherapeutics.com |
Kriya Therapeutics develops gene therapies for prevalent diseases including diabetes, obesity, and ophthalmology with a vertically integrated discovery, manufacturing, and clinical-development platform. Patients with chronic conditions are the eventual customer base. Kriya operates GMP manufacturing facilities in-house rather than outsourcing.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-09-10 | Funding round | $320.8M | undisclosed |
Detected tech stack
Cloudflare, WordPress, Amazon Web Services, Matomo Analytics, Modernizr, Yoast SEO 27.4, Google Analytics, Google Tag Manager, Jabmo, jQuery Migrate 3.4.1, DoubleClick Floodlight, Choices
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $320.8M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $400.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | kriyatherapeutics.com, read 2026-05-05 |
| Description | self-reported | kriyatherapeutics.com, read 2026-05-05 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $320.8M, 2025-09-10 → Funding round, $320.8M, 2025-09-10, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $320.8M, 2025-09-10 → Funding round, $320.8M, 2025-09-10 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes